3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
4
Phase NA
1
Phase 4
1
Phase 1/2
1
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Leukemia, Myeloid, Acute
69
Multiple Myeloma
44
Precursor Cell Lymphoblastic Leukemia-Lymphoma
42
Myelodysplastic Syndromes
37
Lymphoma
37
Leukemia, Lymphocytic, Chronic, B-Cell
37
Lymphoma, Non-Hodgkin
33
Leukemia
32
Recurrence
31
Lymphoma, B-Cell
30
Melanoma
27
Lymphoma, Large B-Cell, Diffuse
22
Ovarian Neoplasms
17
Lymphoma, Mantle-Cell
17
Lymphoma, Follicular
16
Hematologic Neoplasms
16
Carcinoma, Non-Small-Cell Lung
16
Burkitt Lymphoma
16
Neoplasms
15
Lymphoma, B-Cell, Marginal Zone
13
Hodgkin Disease
13
Carcinoma, Renal Cell
12
Head and Neck Neoplasms
11
Neuroblastoma
10
Leukemia, Biphenotypic, Acute
10
Graft vs Host Disease
10
Neoplasms, Plasma Cell
9
Neoplasm Metastasis
9
Colorectal Neoplasms
9
Breast Neoplasms
9
Interventions
ibrutinib
3
Vincristine
2
Methotrexate
2
tozasertib
1
thymoglobulin
1
romiplostim
1
pembrolizumab
1
pegaspargase
1
palbociclib
1
obinutuzumab
1
lucatumumab
1
fludarabine
1
fenebrutinib
1
enzastaurin
1
duvelisib
1
Receptors, Chimeric Antigen
1
Prednisone
1
Prednisolone
1
Hydrocortisone
1
Hu-Mik-beta-1 monoclonal antibody
1
Doxorubicin
1
Dasatinib
1
Cytarabine
1
Cyclophosphamide
1
Busulfan
1
Azacitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Leukemia, Lymphoid
×
fludarabine
×
Clear all
NCT02916979
2023-10-18
FluBuATG
Dartmouth-Hitchcock Medical Center
Phase 1
Completed
20 enrolled